Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7777035 Azaindazole compounds and methods of use

Patent 7777035 was granted and assigned to ChemoCentryx on August, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

ChemoCentryx

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

77770350

Patent Inventor Names

Kevin Lloyd Greenman0

Yandong Li0

Yibin Zeng0

Yuan Xu0

Andrew M. K. Pennell0

John J. Kim Wright0

Lianfa Li0

Manmohan R. Leleti0

...

Date of Patent

August 17, 2010

Patent Application Number

117522010

Date Filed

May 22, 2007

Patent Citations Received

‌

US Patent 12083114 Inhibitors of SARM1 in combination with neuro-protective agents

Patent Primary Examiner

Emily Bernhardt

Patent abstract

Methods are provided for the synthesis of 1-[4-(substituted phenyl)-piperazin-1-yl ] -2- [3-(1H-imidazol-2-yl)-pyrazolo [3,4-b]pyridin-1-yl]-ethanone compounds via construction of the imidazole portion onto the corresponding aldehyde or nitrile compounds.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7777035 Azaindazole compounds and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API